Novel Insights on the Role of Cardiac Computed Tomography in the Primary Prevention of Atherosclerotic Cardiovascular Disease by Miguel Cainzos-Achirica, MD, PhD, MPH 08.21.20
From CME Admins
views
Houston Methodist is committed to excellence in research, teaching, patient care and the advancement of the art and science of medicine. Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This website uses cookies to improve website functionality and performance, to analyze website traffic, and to provide you with a more personalized experience. To find out more about the cookies we use, see our Digital Privacy Policy, Disclaimer & Terms of Use.From CME Admins
Miguel Cainzos-Achirica, MD, PhD, MPH
Associate Director in Cardiovascular Disease Prevention, Houston Methodist DeBakey Heart & Vascular Center
Scientist, Department of Cardiology
Houston Methodist
The coronary artery calcium (CAC) score is a guideline-endorsed tool for further risk assessment in the primary prevention of cardiovascular disease (CVD). Miguel Cainzos-Achirica, MD, PhD, MPH, will discuss his recent and upcoming research on novel roles that CAC may have in the primary prevention of CVD, including its utility guiding a personalized, safe use of low-dose aspirin and add-on other medications in highest risk primary prevention individuals. He also will discuss enriching randomized controlled trials of novel pharmacotherapies in the primary prevention setting. Finally, he will explain the potential role of coronary computed tomography angiography in the youngest adults at increased average CVD risk.
Introduction by: Khurram Nasir, MD, Co-Director of the Center for Outcomes Research at Houston Methodist.
Recorded in the Houston Methodist Research Institute Ernest H. Cockrell Boardroom R2-311 on Friday, August 21, 2020.